MAZE
Maze Therapeutics, Inc.
There isn't enough reported data to score MAZE yet.
MAZE Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
MAZE's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
MAZE PE Valuation
MAZE has no meaningful PE right now: it lost money over the past year.
MAZE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect MAZE's losses to grow, with revenue declining. However, they disagree widely on these estimates.
MAZE Earnings Per Share
MAZE lost $2.47 per share over the past year, a bigger loss than the year before.
MAZE Quarterly Revenue
MAZE's revenue has slid since its 2024 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -133% | N/A |
| Q3 2024 | -969% | N/A |
| Q2 2024 | 85% | N/A |
MAZE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$33.1M | -$8.4M |
| Q2 2026 | -$15.2M | +$15.3M |
| Q1 2026 | -$39.2M | -$9.4M |
| Q4 2025 | -$27.8M | -$4.7M |
| Q3 2025 | -$24.7M | -$1.4M |
| Q2 2025 | -$30.4M | -121% |
| Q1 2025 | -$29.8M | -$6.1M |
| Q4 2024 | -$23.1M | -$2.4M |
MAZE has burned cash in almost every quarter: −$115M over the past year, against −$108M the year before.
MAZE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.2% | +1.9M shares |
| 1 year | +33% | +15.1M shares |
MAZE has 61M diluted shares, up 33% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
MAZE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | -5.5x | Net Cash |
| Q4 2024 | -3.0x | Net Cash |
| Q3 2024 | -1.2x | Net Cash |
| Q2 2024 | -1.6x | Net Cash |
MAZE has more cash than debt.
MAZE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.4 | Neutral |
| Stochastic | 90.0 | Overbought |
MAZE's weekly RSI is 64 (neutral) and its Stochastic is 90 (overbought).
MAZE PE vs Healthcare Sector
MAZE has no meaningful PE right now: it lost money over the past year.
MAZE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.0 | 20% above |
| 20 week MA | $28.5 | 27% above |
| 50 week MA | $32.8 | 10% above |
MAZE is in an uptrend: it's above all three of its weekly moving averages, and 10% above its 50-week average.
MAZE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $16.0 | $42.1 | +164% |
| 2026 YTD | $42.1 | $36.1 | -14% |
MAZE has finished every year since 2025 higher, and it's down 14% so far in 2026.